Impact Factor 2.635 | CiteScore 2.99
More on impact ›

Mini Review ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Neurol. | doi: 10.3389/fneur.2019.01248

Intracranial Stenting: Is it still an option for treatment of patients with intracranial atherosclerosis?

  • 1Faculty of Medicine, Cairo University, Egypt
  • 2Ospedale Niguarda Ca' Granda, Italy
  • 3Faculty of Medicine, Al-Azhar University, Egypt
  • 4Faculty of Medicine, Alexandria University, Egypt

Intracranial atherosclerotic disease (ICAD) represents a major cause of recurrent stroke and transient ischemic attacks. ICAD continues to be a disease without an effective method of reducing risk of recurrent stroke and death even with aggressive highly monitored medical treatment. We reviewed Data from three randomized controlled studies that published comparing intracranial stenting versus medical treatment for symptomatic severe ICAD. Ethnic, demographic, clinical and procedural differences were found among the data from those trials that might influence their results. Future research should aim at establishing refined selection criteria that can identify high-risk ICAD patients who may benefit from intracranial stenting.

Keywords: Intracranial atherosclerosis, medical therapy, endovascular treatment, Stroke, Angioplasty, intracranial stenting

Received: 03 Jul 2019; Accepted: 08 Nov 2019.

Copyright: © 2019 Abualhasan, Abd-Allah, Pero, Sobh, Mansour, El-Serafy and Boccardi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Prof. Foad Abd-Allah, Faculty of Medicine, Cairo University, Cairo, Cairo, Egypt,